Stockreport
Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now? [Yahoo! Finance]
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
on April 7 that its wholly-owned subsidiary, Halozyme Hypercon, Inc., entered into a global exclusive collaboration and license agreement with Vertex Pharmaceuticals Incorporated. According to the collaboration, Vertex has licensed Halozyme Therapeutics' (NASDAQ:HALO) Hypercon™ technology for use in up to three drug targets. Management stated that Hypercon™ is an innovative microparticle technology allowing for hyperconcentration of drugs and biologics, reducing injection volume for the same dosage and enabling convenient, at-home administration. Is Halozyme Therapeutics, Inc. (HALO) the Unstoppable Growth Stock to Invest in Now? Helen Torley, President and Chief Executive Officer of Halozyme Therapeutics, Inc. (NASDAQ:HALO), stated that the collaboration highlights the potential and versatility of the company's Hypercon technology to “enable small volume, patient-delivered next-generation biologics”. The terms of the exclusive agreement state that Vertex will make a $15 million
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VRTX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VRTX alerts
VRTX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
NEWS
NEWS
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Globe and Mail, The (Toronto, Canada)][Globe and Mail, The]
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Yahoo! Finance][Yahoo! Finance]
- How an unsolved medical mystery became a life-saving breakthrough [USA TODAY][USA TODAY]
- Is Vertex Pharmaceuticals' Empire in Trouble? [Globe and Mail, The (Toronto, Canada)][Globe and Mail, The]
- Is Vertex Pharmaceuticals' Empire in Trouble? [Yahoo! Finance][Yahoo! Finance]
- More
VRTX
SEC Filings
SEC Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- VRTX's page on the SEC website
- More